drugset / Trial / NCT00487136
Interaction Between ABT-335, Rosuvastatin and Warfarin
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multiple-dose, double-blind, randomized, single-center, parallel-group study in adult male subjects in general good health.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-335 | Small molecule | 135 mg | — |
| Subject | Rosuvastatin | Small molecule | 5 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Comparator | Warfarin | Small molecule | — | — |
Indications
No indication recorded.